Essa Pharma Inc Reports Results For The Quarter Ended In September: Earnings Summary

ESSA Pharma

13/12/2022 12:32

* ESSA Pharma Inc  EPIX.OQ  reported a quarterly adjusted
loss
of 14 cents​​ per share for the quarter ended in September. The
mean expectation of four analysts for the quarter was for a loss
of 28 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * ESSA Pharma Inc's reported EPS for the quarter was a loss
of 14
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * ESSA Pharma Inc shares had risen by 76.4% this quarter and
lost 77.4% so far this year.
    * The company reported a quarterly loss of $6.32 million.
    * Wall Street's median 12-month price target for ESSA Pharma
Inc
is $23.00 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 4 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data December
13 at 12:31 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.27          -0.14          Beat
 Jun. 30 2022      -0.27          -0.20          Beat
 Mar. 31 2022      -0.25          -0.25          Met
 Dec. 31 2021      -0.23          -0.21          Beat